Literature DB >> 1297824

The family of protein kinase C in transmembrane signalling for cellular regulation.

Y Asaoka1, K Yoshida, M Oka, T Shinomura, H Koide, K Ogita, U Kikkawa, Y Nishizuka.   

Abstract

Signal-induced hydrolysis of inositol phospholipid produces two second messengers, diacylglycerol and inositol trisphosphate. Diacylglycerol activates protein kinase C, whereas inositol trisphosphate mobilizes Ca2+ from its internal store. Analogously, signal-induced hydrolysis of choline phospholipid generates two second messengers, unsaturated free fatty acid and lysophosphatidylcholine. The free fatty acid synergizes with diacylglycerol to activate protein kinase C and causes full activation of the enzyme even at the basal level of Ca2+. On the other hand, lysophosphatidylcholine dramatically enhances cellular responses such as cell proliferation and differentiation under the conditions where diacylglycerol and Ca2+ are available. It is likely that all of the immediate products of signal-induced degradation of inositol and choline phospholipids are involved directly in concert in the transmembrane control of cellular functions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1297824     DOI: 10.3177/jnsv.38.special_7

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  3 in total

1.  Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element.

Authors:  J W Soh; E H Lee; R Prywes; I B Weinstein
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

2.  Cholecystokinin-octapeptide affects the fluorescence signal of a single pancreatic acinar cell loaded with the acrylodan-labelled MARCKS peptide, a protein kinase C substrate.

Authors:  A Ngezahayo; F Lang; H A Kolb
Journal:  Pflugers Arch       Date:  1995-04       Impact factor: 3.657

3.  Regulation of gap junctional coupling in isolated pancreatic acinar cell pairs by cholecystokinin-octapeptide, vasoactive intestinal peptide (VIP) and a VIP-antagonist.

Authors:  A Ngezahayo; H A Kolb
Journal:  J Membr Biol       Date:  1994-04       Impact factor: 1.843

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.